eMedicine Specialties > Sports Medicine > Foot and Ankle

Calcaneofibular Ligament Injury: Treatment & Medication

Author: Bryan L Reuss, MD, Orthopedic Surgeon, Orlando Orthopedic Center
Coauthor(s): Michael C Wadman, MD, Assistant Professor, Department of Surgery, Section of Emergency Medicine, University of Nebraska College of Medicine; Randy Schwartzberg, MD, Director of Sports Medicine Education, Department of Orthopedic Surgery, Orlando Regional Healthcare System
Contributor Information and Disclosures

Updated: Jan 2, 2008

Treatment

Acute Phase

Rehabilitation Program

Physical Therapy

Rest, ice, compression, and elevation (RICE) are vital components to a fast recovery.12,17 Nonsteroidal anti-inflammatory drugs (NSAIDs) are appropriate for the presence of pain and swelling.18 Crutches are also acceptable for a short time after the injury occurs until ambulation is pain free. A widely agreed upon finding is that grade I and grade II ligamentous sprains should be treated nonsurgically, and these injuries have good to excellent prognosis with such treatment.17,19 Occasionally, in grade II sprains, a plaster splint may be necessary for 48-72 hours. Reevaluate the injury at this time, and a cast may be applied if the patient continues to have severe pain. Ultimately, it is accepted that grade I and grade II sprains are treated conservatively, whereas the decision to treat grade III lateral ankle sprains (often associated with a complete tear of the ATFL and CFL) is approached on an individual basis.20,21,22

Medical Issues/Complications

Proper assessment and treatment ensure a decreased complication rate for ankle injuries (see Complications, below).

Surgical Intervention

In grade III sprains, many authors support the decision that younger athletes and patients should be treated surgically, whereas older patients should be casted, with the option of a secondary repair at a later time. Other investigators have shown that functional treatment (early controlled movement) is superior to surgical treatment for grade I, II, and III lateral ankle sprains. If acute surgical treatment is chosen, the operation consists of reapproximating the torn ligament with the ankle in a neutral dorsiflexed and slightly everted position.

Consultations

In patients with grade III ankle sprains who present to the ED or a physician's office, a posterior plaster splint and an orthopedic evaluation within 1-2 weeks of the injury is warranted because surgery may be necessary.

Recovery Phase

Rehabilitation Program

Physical Therapy

Whether the immediate treatment is surgical or conservative, rehabilitation of the weakened and often unstable ankle joint is paramount. Once the initial period of immobilization is over, it is important for the patient to begin a thorough rehabilitation program that focuses on muscle strengthening and proprioception. Implementation of ROM and ankle-strengthening exercises when the patient is pain free is important. Because immobilization and early mobilization with ankle rehabilitation provide equal long-term stability to the ankle, early mobilization should be the goal when possible; this therapy allows for an earlier return to work and activities and is more comfortable to the patient. The maximum therapy benefit is gained with at least 10 weeks of rigorous rehabilitation. Dedication of the patient to his/her rehabilitation reduces the chance of further injury to the ankle joint.

Medical Issues/Complications

See Complications, below.

Maintenance Phase

Rehabilitation Program

Physical Therapy

Prevention is the foundation of a good maintenance phase therapy. Stretching of the ankle, continuous strengthening exercises, and ankle stabilizers are important in preventing further injury. The patient should also apply common sense when encountering situations that may place the ankle at risk for another inversion injury. If chronic instability occurs in day-to-day situations in which a brace is impractical, surgical reapproximation of the torn ligament or ligamentous reconstruction is indicated to increase stability.

Medical Issues/Complications

See Complications, below.

Medication

The goal of pharmacotherapy is to decrease the patient's pain and inflammation.

Nonsteroidal anti-inflammatory drugs

NSAIDs are most commonly used for the relief of mild to moderate pain. Although the effects of NSAIDs in the treatment of pain tend to be patient specific, ibuprofen is usually the DOC for initial therapy. Other options include naproxen and ketoprofen.


Ibuprofen (Motrin, Advil, Ibuprin, Nuprin)

DOC for the treatment of mild to moderate pain if no contraindications are present. Inhibits inflammatory reactions and pain, probably by decreasing the activity of the enzyme cyclooxygenase, which results in the inhibition of prostaglandin synthesis.

Adult

400 mg PO q4-6h, 600 mg PO q6h, or 800 mg PO q8h, while symptoms persist; not to exceed 3.2 g/d

Pediatric

<12 years: Not established
>12 years: Administer as in adults

Probenecid may increase the concentrations and, possibly, the toxicity of NSAIDs; may decrease the effect of loop diuretics when administered concurrently; PT duration may increase when administered concurrently with anticoagulants; instruct patients to watch for the signs and symptoms of bleeding; ibuprofen and other NSAIDs may increase serum lithium levels and the risk of methotrexate toxicity

Documented hypersensitivity; avoid in patients in whom aspirin, iodides, or other NSAIDs induce hypersensitivity because of potential cross-sensitivity to other NSAIDs; contraindicated in the presence of diagnosed peptic ulcer disease, recent GI bleed or perforation, renal insufficiency, and in those at high risk of bleeding

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

Caution in patients with congestive heart failure, hypertension, and decreased renal and hepatic function


Naproxen (Naprosyn, Aleve)

Used for the relief of mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing the activity of the enzyme cyclooxygenase, which results in a decrease of prostaglandin synthesis.

Adult

200-250 mg PO q6-8h or 500 PO mg bid; not to exceed 1.25 g/d; may increase to 1.5 g/d for limited periods

Pediatric

<12 years: Not established
>12 years: Administer as in adults

Probenecid and lithium may increase the concentrations and, possibly, the toxicity of NSAIDs; the effect of loop diuretics may decrease when administered concurrently; PT duration may increase when administered concurrently with anticoagulants; instruct patients to watch for the signs and symptoms of bleeding; concurrent administration with phenytoin may increase serum phenytoin levels, resulting in an increase in the pharmacologic and toxic effects of phenytoin

Documented hypersensitivity; contraindicated in those with diagnosed peptic ulcer disease, recent GI bleed or perforation, renal insufficiency, and those at high risk of bleeding

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

Acute renal insufficiency, hyperkalemia, hyponatremia, interstitial nephritis, and renal papillary necrosis may occur; increases the risk of acute renal failure in patients with preexisting renal disease or compromised renal perfusion; low white blood cell counts occur rarely and usually return to normal in ongoing therapy; discontinuation may be necessary if leukopenia, granulocytopenia, or thrombocytopenia persists


Ketoprofen (Orudis, Actron, Oruvail)

Initially administer small doses to patients with a small body size, elderly patients, and patients with renal or liver disease. Doses >75 mg do not increase therapeutic effects. Administer high doses with caution, and closely observe the patient for a response.

Adult

25-50 mg PO q6-8h prn; not to exceed 300 mg/d

Pediatric

<12 years: Not established
>12 years: Administer as in adults

Probenecid and lithium may increase the concentrations and, possibly, the toxicity of NSAIDs; the effect of loop diuretics may decrease when administered concurrently; PT duration may increase when administered concurrently with anticoagulants; concurrent administration with phenytoin may increase serum phenytoin levels, resulting in an increase in the pharmacologic and toxic effects of phenytoin.

Pregnancy

B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

Avoid use in patients diagnosed with GI disease, cardiovascular disease, renal or hepatic impairment, and patients receiving anticoagulants.


Celecoxib (Celebrex)

Primarily inhibits COX-2. COX-2 is considered an inducible isoenzyme and is induced by pain and inflammatory stimuli. Inhibition of COX-1 may contribute to NSAID GI toxicity. At therapeutic concentrations, COX-1 isoenzyme is not inhibited, thus the incidence of GI toxicity, such as endoscopic peptic ulcers, bleeding ulcers, perforations, and obstructions, may be decreased when compared with nonselective NSAIDs. Seek the lowest dose for each patient.

Neutralizes circulating myelin antibodies through anti-idiotypic antibodies; downregulates proinflammatory cytokines, including INF-gamma; blocks Fc receptors on macrophages; suppresses inducer T and B cells and augments suppressor T cells; blocks complement cascade; promotes remyelination; may increase CSF IgG (10%).

Has a sulfonamide chain and is primarily dependent upon cytochrome P450 enzymes (a hepatic enzyme) for metabolism.

Adult

200 mg/d PO qd; alternatively, 100 mg PO bid

Pediatric

Not established

Coadministration with fluconazole may cause an increase in celecoxib plasma concentrations because of inhibition of celecoxib metabolism; coadministration of celecoxib with rifampin may decrease celecoxib plasma concentrations.

Pregnancy

D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus

Precautions

May cause fluid retention and peripheral edema; caution in patients with compromised cardiac function, hypertension, conditions predisposing to fluid retention; caution in the presence of severe heart failure and hyponatremia because circulatory hemodynamics may deteriorate; NSAIDs may mask the usual signs of infection; caution in the presence of existing controlled infections; evaluate therapy when symptoms or laboratory results suggest liver dysfunction

More on Calcaneofibular Ligament Injury

Overview: Calcaneofibular Ligament Injury
Differential Diagnoses & Workup: Calcaneofibular Ligament Injury
Treatment & Medication: Calcaneofibular Ligament Injury
Follow-up: Calcaneofibular Ligament Injury
Multimedia: Calcaneofibular Ligament Injury
References

References

  1. Coughlin MJ, Mann RA, eds. Surgery of the Foot and Ankle. 7th ed. St. Louis, Mo: Mosby; 1999:114-30.

  2. Rosen P, Barkin RM, Hayden SR, Schaider JJ, Wolfe R. The 5 Minute Emergency Medicine Consult. Philidelphia, Pa: Lippincott Williams & Wilkins; 1999:70-1.

  3. Mellion MB, Walsh WM, Shelton GL, eds. The Team Physician's Handbook. St. Louis, Mo: Mosby; 1997:584.

  4. Skinner HB. Current Diagnosis and Treatment in Orthopedics. Stamford, Conn: Appleton & Lange; 1995.

  5. Lutter LD, Mizel MS, Pfeffer GB, eds. Orthopaedic Knowledge Update: Foot and Ankle. Rosemont, Ill: American Academy of Orthopaedic Surgeons; 1994:241-51.

  6. Mayeda DV. Ankle and foot. In: Rosen P, Barkin RM, Danzl DF, et al, eds. Emergency Medicine Concepts and Clinical Practice. 3rd ed. St. Louis, Mo: Mosby Year-Book; 1992:745-57.

  7. Gerbert J, Burns A. Acute soft tissue trauma of the ankle. In: Scurran BL, ed. Foot and Ankle Trauma. New York, NY: Churchill Livingstone; 1989:571-8.

  8. Hutton PAN. Ankle lesions. In: Jenkins DHR, ed. Ligament Injuries and Their Treatment. Rockville, Md: Aspen Publication; 1985:95-111.

  9. Kerkhoffs GM, Rowe BH, Assendelft WJ, et al. Immobilisation and functional treatment for acute lateral ankle ligament injuries in adults. Cochrane Database Syst Rev. 2002;3:CD003762. [Medline].

  10. Wexler RK. The injured ankle. Am Fam Physician. Feb 1 1998;57(3):474-80. [Medline][Full Text].

  11. Taser F, Shafiq Q, Ebraheim NA. Anatomy of lateral ankle ligaments and their relationship to bony landmarks. Surg Radiol Anat. Aug 2006;28(4):391-7. [Medline].

  12. Birrer RB. Ankle injuries and the family physician. J Am Board Fam Pract. Oct-Dec 1988;1(4):274-81. [Medline].

  13. Haraguchi N, Toga H, Shiba N, Kato F. Avulsion fracture of the lateral ankle ligament complex in severe inversion injury: incidence and clinical outcome. Am J Sports Med. Jul 2007;35(7):1144-52. [Medline].

  14. Reuss BL. Managing ankle injuries: follow the rules?. J Musculoskelet Med. 2004;21(3):155-64.

  15. Chou MC, Yeh LR, Chen CK, et al. Comparison of plain MRI and MR arthrography in the evaluation of lateral ligamentous injury of the ankle joint. J Chin Med Assoc. Jan 2006;69(1):26-31. [Medline].

  16. Duc SR, Mengiardi B, Pfirrmann CW, Hodler J, Zanetti M. Improved visualization of collateral ligaments of the ankle: multiplanar reconstructions based on standard 2D turbo spin-echo MR images. Eur Radiol. May 2007;17(5):1162-71. [Medline].

  17. McDowell LD, Seymour SF. Diagnosis and treatment of ankle sprains. Nurse Pract. Mar 1994;19(3):36-9, 43. [Medline].

  18. Cukiernik VA, Lim R, Warren D, et al. Naproxen versus acetaminophen for therapy of soft tissue injuries to the ankle in children. Ann Pharmacother. Sep 2007;41(9):1368-74. [Medline].

  19. Evans GA, Hardcastle P, Frenyo AD. Acute rupture of the lateral ligament of the ankle. To suture or not to suture?. J Bone Joint Surg Br. Mar 1984;66(2):209-12. [Medline][Full Text].

  20. Samoto N, Sugimoto K, Takaoka T, et al. Comparative results of conservative treatments for isolated anterior talofibular ligament (ATFL) injury and injury to both the ATFL and calcaneofibular ligament of the ankle as assessed by subtalar arthrography. J Orthop Sci. Jan 2007;12(1):49-54. [Medline].

  21. Kerkhoffs GM, Struijs PA, Marti RK, et al. Different functional treatment strategies for acute lateral ankle ligament injuries in adults. Cochrane Database Syst Rev. 2002;3:CD002938. [Medline].

  22. Kaikkonen A, Kannus P, Järvinen M. Surgery versus functional treatment in ankle ligament tears. A prospective study. Clin Orthop Relat Res. May 1996;326:194-202. [Medline].

  23. Broström L. Sprained ankles. V. Treatment and prognosis in recent ligament ruptures. Acta Chir Scand. Nov 1966;132(5):537-50. [Medline].

  24. Caprio A, Oliva F, Treia F, Maffulli N. Reconstruction of the lateral ankle ligaments with allograft in patients with chronic ankle instability. Foot Ankle Clin. Sep 2006;11(3):597-605. [Medline].

  25. Eiff MP, Smith AT, Smith GE. Early mobilization versus immobilization in the treatment of lateral ankle sprains. Am J Sports Med. Jan-Feb 1994;22(1):83-8. [Medline].

  26. Ferkel RD, Chams RN. Chronic lateral instability: arthroscopic findings and long-term results. Foot Ankle Int. Jan 2007;28(1):24-31. [Medline].

  27. Freeman MA. Instability of the foot after injuries to the lateral ligament of the ankle. J Bone Joint Surg Br. Nov 1965;47(4):669-77. [Medline][Full Text].

  28. Fujii T, Kitaoka HB, Watanabe K, Luo ZP, An KN. Comparison of modified Broström and Evans procedures in simulated lateral ankle injury. Med Sci Sports Exerc. Jun 2006;38(6):1025-31. [Medline].

  29. Grønmark T, Johnsen O, Kogstad O. Rupture of the lateral ligaments of the ankle: a controlled clinical trial. Injury. Feb 1980;11(3):215-8. [Medline].

  30. Haller J, Bernt R, Seeger T, et al. MR-imaging of anterior tibiotalar impingement syndrome: agreement, sensitivity and specificity of MR-imaging and indirect MR-arthrography. Eur J Radiol. Jun 2006;58(3):450-60. [Medline].

  31. Jones AP, Sidhom S, Sefton G. A minimally invasive surgical technique for augmented reconstruction of the lateral ankle ligaments with woven polyester tape. J Foot Ankle Surg. Nov-Dec 2007;46(6):416-23. [Medline].

  32. Klein J, Schreckenberger C, Röddecker K, Tiling T. [Surgical or conservative treatment of recent rupture of the lateral ligament of the upper ankle joint. Randomized clinical study] [German]. Unfallchirurg. Apr 1988;91(4):154-60. [Medline].

  33. Korkala O, Rusanen M, Jokipii P, Kytömaa J, Avikainen V. A prospective study of the treatment of severe tears of the lateral ligament of the ankle. Int Orthop. 1987;11(1):13-7. [Medline].

  34. Lui TH. Endoscopic lateral calcaneal ostectomy for calcaneofibular impingement. Arch Orthop Trauma Surg. May 2007;127(4):265-7. [Medline].

  35. Møller-Larsen F, Wethelund JO, Jurik AG, de Carvalho A, Lucht U. Comparison of three different treatments for ruptured lateral ankle ligaments. Acta Orthop Scand. Oct 1988;59(5):564-6. [Medline].

  36. Niedermann B, Andersen A, Andersen SB, et al. Rupture of the lateral ligaments of the ankle: operation or plaster cast? A prospective study. Acta Orthop Scand. Oct 1981;52(5):579-87. [Medline].

  37. Prins JG. Diagnosis and treatment of injury to the lateral ligament of the ankle. A comparative clinical study. Acta Chir Scand Suppl. 1978;486:3-149. [Medline].

  38. Tokuda O, Awaya H, Taguchi K, Matsunga N. Kinematic MRI of the normal ankle ligaments using a specially designed passive positioning device. Foot Ankle Int. Nov 2006;27(11):935-42. [Medline].

  39. Trevino SG, Davis P, Hecht PJ. Management of acute and chronic lateral ligament injuries of the ankle. Orthop Clin North Am. Jan 1994;25(1):1-16. [Medline].

Further Reading

Keywords

ankle ligament injury, ankle injury, ligament injury, lateral ankle injury, sprain, ankle sprain, lateral ankle sprain, CFL injury

Contributor Information and Disclosures

Author

Bryan L Reuss, MD, Orthopedic Surgeon, Orlando Orthopedic Center
Disclosure: Nothing to disclose.

Coauthor(s)

Michael C Wadman, MD, Assistant Professor, Department of Surgery, Section of Emergency Medicine, University of Nebraska College of Medicine
Michael C Wadman, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Randy Schwartzberg, MD, Director of Sports Medicine Education, Department of Orthopedic Surgery, Orlando Regional Healthcare System
Randy Schwartzberg, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Medical Association, American Orthopaedic Society for Sports Medicine, Arthroscopy Association of North America, Florida Medical Association, Southern Medical Association, and Southern Orthopaedic Association
Disclosure: Nothing to disclose.

Medical Editor

Janos P Ertl, MD, Clinical Assistant Professor, Department of Orthopedic Surgery, University of California at Davis; Director of Amputee Clinic, Chief of Orthopedic Trauma, Kaiser Hospital
Janos P Ertl, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, Hungarian Medical Association of America, Orthopaedic Trauma Association, and Sierra Sacramento Valley Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

CME Editor

Jon B Whitehurst, MD, Clinical Instructor of Surgery, University of Illinois College of Medicine; Partner and Executive Board Member, Rockford Orthopedic Associates; Orthopedic Chairman, Rockford Memorial Hospital
Jon B Whitehurst, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, and Arthroscopy Association of North America
Disclosure: Nothing to disclose.

Chief Editor

Sherwin SW Ho, MD, Associate Professor, Department of Surgery, Section of Orthopedic Surgery and Rehabilitation Medicine, University of Chicago
Sherwin SW Ho, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Orthopaedic Society for Sports Medicine, and Arthroscopy Association of North America
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.